Evaluating the risk of patient re-identification from adverse drug event reports

BACKGROUND: Our objective was to develop a model for measuring re-identification risk that more closely mimics the behaviour of an adversary by accounting for repeated attempts at matching and verification of matches, and apply it to evaluate the risk of re-identification for Canada’s post-marketing...

Descripción completa

Detalles Bibliográficos
Autores principales: El Emam, Khaled, Dankar, Fida K, Neisa, Angelica, Jonker, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137558/
https://www.ncbi.nlm.nih.gov/pubmed/24094134
http://dx.doi.org/10.1186/1472-6947-13-114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137558/
https://www.ncbi.nlm.nih.gov/pubmed/24094134
http://dx.doi.org/10.1186/1472-6947-13-114

Ejemplares similares